Press Release
Category Added in a WPeMatico Campaign
-
Business Wire3 weeks ago
Gilead Prices $3 Billion of Senior Unsecured Notes
FOSTER CITY, Calif.–(BUSINESS WIRE)–#GILD–Gilead Sciences, Inc. (Nasdaq: GILD), a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for…
Read More » -
Business Wire3 weeks ago
Gilead Prices $3 Billion of Senior Unsecured Notes
FOSTER CITY, Calif.–(BUSINESS WIRE)–#GILD–Gilead Sciences, Inc. (Nasdaq: GILD), a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for…
Read More » -
Business Wire3 weeks ago
Gilead Prices $3 Billion of Senior Unsecured Notes
FOSTER CITY, Calif.–(BUSINESS WIRE)–#GILD–Gilead Sciences, Inc. (Nasdaq: GILD), a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for…
Read More » -
Business Wire3 weeks ago
Nexon and Tencent Extend Publishing Partnership for Dungeon&Fighter PC in China
Ten-Year Extension Offers Continuity for Players TOKYO–(BUSINESS WIRE)–NEXON Co., Ltd. (Nexon) (3659.TO), a global leader in online games, today announced…
Read More » -
Business Wire3 weeks ago
QAD | Redzone Champions of Manufacturing Thailand Kicks Off in Bangkok, Igniting the Next Era of AI-Powered Manufacturing
The future of manufacturing has officially arrived in Asia-Pacific BANGKOK–(BUSINESS WIRE)–QAD | Redzone, the company delivering the leading manufacturing platform,…
Read More » -
Business Wire3 weeks ago
QAD | Redzone Champions of Manufacturing Thailand Kicks Off in Bangkok, Igniting the Next Era of AI-Powered Manufacturing
The future of manufacturing has officially arrived in Asia-Pacific BANGKOK–(BUSINESS WIRE)–QAD | Redzone, the company delivering the leading manufacturing platform,…
Read More » -
Business Wire3 weeks ago
QAD | Redzone Champions of Manufacturing Thailand Kicks Off in Bangkok, Igniting the Next Era of AI-Powered Manufacturing
The future of manufacturing has officially arrived in Asia-Pacific BANGKOK–(BUSINESS WIRE)–QAD | Redzone, the company delivering the leading manufacturing platform,…
Read More » -
Business Wire3 weeks ago
Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet
TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (headquartered in Tokyo; President and Representative Director: Toshiaki Nagasato) today announced that the results…
Read More » -
Business Wire3 weeks ago
Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet
TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (headquartered in Tokyo; President and Representative Director: Toshiaki Nagasato) today announced that the results…
Read More » -
Business Wire3 weeks ago
Meiji Seika Pharma: Positive Results from the Phase III Integral-1 Trial of Nacubactam, a Novel β-Lactamase Inhibitor, in Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis ― Published in The Lancet
TOKYO–(BUSINESS WIRE)–Meiji Seika Pharma Co., Ltd. (headquartered in Tokyo; President and Representative Director: Toshiaki Nagasato) today announced that the results…
Read More »